Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Thiocarbamate derivatives as a2a inhibitors, pharmaceutical composition thereof … 2020-9-09 2021-3-11
2-oxo-thiazole derivatives as a2a inhibitors and compounds for use in the … 2020-8-14 2021-7-01
Anti-tigit antibodies 2020-1-23 2020-3-31
Anti-tigit antibodies 2020-1-07 2020-7-16
Use of an inhibitor of an ent family transporter in the treatment of cancer and … 2019-9-27 2020-4-02
Non brain penetrant A2A inhibitors and methods for use in the treatment of … 2019-9-26 2022-8-30 2022-8-30
Thiocarbamate derivatives as A2A inhibitors, pharmaceutical compositions … 2019-9-11 2021-8-06
USE OF AN ENT FAMILY CARRIER INHIBITOR IN THE TREATMENT OF CANCER AND … 2018-9-27 2020-4-07
COMBINATION OF AN A2A RECEPTOR INHIBITOR AND AN ANTI-CANCER AGENT 2018-9-27 2020-7-06 2020-7-06
NON-BRAIN A2A INHIBITORS AND METHODS OF USE IN THE TREATMENT OF CANCERS 2018-9-27 2020-4-03
PHARMACEUTICAL COMPOSITION COMPRISING THIOCARBAMATE DERIVATIVES A2A INHIBITORS 2018-9-11 2020-6-03
Anti-tigit antibodies 2018-7-26 2019-1-31
2-oxo-thiazole derivatives as a2a inhibitors and compounds for use in the … 2018-3-30 2018-10-04
THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS AND METHODS FOR USE IN CANCER … 2018-3-28 2019-6-12
Treatment method utilizing pyrrolidine-2, 5-dione derivatives as ido1 … 2018-3-23 2018-8-02
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods … 2018-3-12 2018-7-27
ANTI-TIGIT ANTIBODIES 2017-7-31 2019-1-23 2019-1-23
Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for … 2017-7-11 2017-12-07
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods … 2016-8-04 2018-8-09
Polymorph forms of pyrrolidine-2,5-dione derivatives, pharmaceutical … 2016-5-13 2017-2-16
POLYMORPHIN FORMS OF PIRROLIDINE-2,5-DIONA DERIVATIVES, PHARMACEUTICAL … 2016-5-12 2017-8-02
Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body 2016-5-12 2021-3-16 2021-3-16
COMBINED THERAPIES THAT INCLUDE A PIRROLIDIN-2,5-DIONA IDO1 INHIBITOR AND ANTI- … 2016-5-12 2017-8-02
Novel 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and … 2015-7-24 2015-11-19
DERIVATIVES OF PIRROLIDINA-2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS … 2015-5-14 2016-10-05
Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for … 2015-5-14 2018-6-14
Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for … 2015-5-14 2015-11-19
DERIVATIVES OF PIRROLIDINA-2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS … 2015-5-14 2017-2-23
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods … 2015-3-17 2015-9-24
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods … 2015-3-17 2015-9-24
Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and … 2015-2-11 2015-8-20
Novel 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and … 2014-11-07 2016-9-15
4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods … 2014-11-07 2015-5-14
NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHOD … 2014-11-06 2015-9-22 2015-9-22
NOVEL 3- (INDOL-3-YL) -PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND … 2014-11-06 2015-9-22 2015-9-22
PYRROLIDINE-2,5-DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF … 2014-10-21 2015-9-22 2015-9-22